Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements

Laura De Lellis, Maria Cristina Curia, Teresa Catalano, Simona De Toffol, Chiara Bassi, Cristina Mareni, Lucio Bertario, Pasquale Battista, Renato Mariani-Costantini, Paolo Radice, Alessandro Cama

Research output: Contribution to journalArticle

Abstract

Large genomic rearrangements are recognized as playing a pathogenic role in an increasing number of human genetic diseases. It is important to develop efficient methods for the routine detection and confirmation of these germline defects. Multiplex ligation-dependent probe amplification (MLPA) is considered an early step for molecular diagnosis of several genetic disorders. However, artifacts might hamper the interpretation of MLPA analysis, especially when rearrangements involve a single exon. Therefore, rearrangements must be verified by two independent methods. In this study, we developed nonfluorescent multiplex-PCR coupled to high-performance liquid chromatography (NFMP-HPLC) and analyzed whether the use of this method combined with MLPA could be helpful in the detection and confirmation of gross MSH2 and MLH1 genomic rearrangements. A total of nine nonfluorescent multiplex-PCRs were developed to analyze the 16 MSH2 and 19 MLH1 exons. Reliable multiplex amplifications and nonfluorescent peak quantitation were obtained with a limited number of cycles (≤ 25) using a denaturing HPLC (DHPLC) instrument under nondenaturing conditions. The results obtained by NFMP-HPLC were highly reproducible. The combined use of MLPA and NFMP-HPLC identified and independently confirmed putative MLH1 and MSH2 deletions in eight out of 50 unrelated patients with hereditary nonpolyposis colorectal cancer (HNPCC). In five cases, the deletions affected a single exon and in three cases multiple contiguous exons. These results were in agreement with breakpoint and complementary DNA (cDNA) analyses. Considering that MLPA and NFMP-HPLC are unlikely to be affected by the same artifacts, their combined use could also provide a robust and cost-effective strategy for routine screening and confirmation of putative rearrangements in other genes, especially when a single exon is involved or a precise characterization of breakpoints is not achieved.

Original languageEnglish
Pages (from-to)1047-1056
Number of pages10
JournalHuman Mutation
Volume27
Issue number10
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Multiplex Polymerase Chain Reaction
High Pressure Liquid Chromatography
Exons
Inborn Genetic Diseases
Artifacts
Hereditary Nonpolyposis Colorectal Neoplasms
Medical Genetics
Complementary DNA
Costs and Cost Analysis

Keywords

  • Gene dosage
  • HNPCC
  • MLH1
  • Molecular diagnosis
  • MSH2
  • Semiquantitative analysis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements. / De Lellis, Laura; Curia, Maria Cristina; Catalano, Teresa; De Toffol, Simona; Bassi, Chiara; Mareni, Cristina; Bertario, Lucio; Battista, Pasquale; Mariani-Costantini, Renato; Radice, Paolo; Cama, Alessandro.

In: Human Mutation, Vol. 27, No. 10, 10.2006, p. 1047-1056.

Research output: Contribution to journalArticle

De Lellis, L, Curia, MC, Catalano, T, De Toffol, S, Bassi, C, Mareni, C, Bertario, L, Battista, P, Mariani-Costantini, R, Radice, P & Cama, A 2006, 'Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements', Human Mutation, vol. 27, no. 10, pp. 1047-1056. https://doi.org/10.1002/humu.20386
De Lellis, Laura ; Curia, Maria Cristina ; Catalano, Teresa ; De Toffol, Simona ; Bassi, Chiara ; Mareni, Cristina ; Bertario, Lucio ; Battista, Pasquale ; Mariani-Costantini, Renato ; Radice, Paolo ; Cama, Alessandro. / Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements. In: Human Mutation. 2006 ; Vol. 27, No. 10. pp. 1047-1056.
@article{a634f658ac654eaf8526445f202ddd8e,
title = "Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements",
abstract = "Large genomic rearrangements are recognized as playing a pathogenic role in an increasing number of human genetic diseases. It is important to develop efficient methods for the routine detection and confirmation of these germline defects. Multiplex ligation-dependent probe amplification (MLPA) is considered an early step for molecular diagnosis of several genetic disorders. However, artifacts might hamper the interpretation of MLPA analysis, especially when rearrangements involve a single exon. Therefore, rearrangements must be verified by two independent methods. In this study, we developed nonfluorescent multiplex-PCR coupled to high-performance liquid chromatography (NFMP-HPLC) and analyzed whether the use of this method combined with MLPA could be helpful in the detection and confirmation of gross MSH2 and MLH1 genomic rearrangements. A total of nine nonfluorescent multiplex-PCRs were developed to analyze the 16 MSH2 and 19 MLH1 exons. Reliable multiplex amplifications and nonfluorescent peak quantitation were obtained with a limited number of cycles (≤ 25) using a denaturing HPLC (DHPLC) instrument under nondenaturing conditions. The results obtained by NFMP-HPLC were highly reproducible. The combined use of MLPA and NFMP-HPLC identified and independently confirmed putative MLH1 and MSH2 deletions in eight out of 50 unrelated patients with hereditary nonpolyposis colorectal cancer (HNPCC). In five cases, the deletions affected a single exon and in three cases multiple contiguous exons. These results were in agreement with breakpoint and complementary DNA (cDNA) analyses. Considering that MLPA and NFMP-HPLC are unlikely to be affected by the same artifacts, their combined use could also provide a robust and cost-effective strategy for routine screening and confirmation of putative rearrangements in other genes, especially when a single exon is involved or a precise characterization of breakpoints is not achieved.",
keywords = "Gene dosage, HNPCC, MLH1, Molecular diagnosis, MSH2, Semiquantitative analysis",
author = "{De Lellis}, Laura and Curia, {Maria Cristina} and Teresa Catalano and {De Toffol}, Simona and Chiara Bassi and Cristina Mareni and Lucio Bertario and Pasquale Battista and Renato Mariani-Costantini and Paolo Radice and Alessandro Cama",
year = "2006",
month = "10",
doi = "10.1002/humu.20386",
language = "English",
volume = "27",
pages = "1047--1056",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements

AU - De Lellis, Laura

AU - Curia, Maria Cristina

AU - Catalano, Teresa

AU - De Toffol, Simona

AU - Bassi, Chiara

AU - Mareni, Cristina

AU - Bertario, Lucio

AU - Battista, Pasquale

AU - Mariani-Costantini, Renato

AU - Radice, Paolo

AU - Cama, Alessandro

PY - 2006/10

Y1 - 2006/10

N2 - Large genomic rearrangements are recognized as playing a pathogenic role in an increasing number of human genetic diseases. It is important to develop efficient methods for the routine detection and confirmation of these germline defects. Multiplex ligation-dependent probe amplification (MLPA) is considered an early step for molecular diagnosis of several genetic disorders. However, artifacts might hamper the interpretation of MLPA analysis, especially when rearrangements involve a single exon. Therefore, rearrangements must be verified by two independent methods. In this study, we developed nonfluorescent multiplex-PCR coupled to high-performance liquid chromatography (NFMP-HPLC) and analyzed whether the use of this method combined with MLPA could be helpful in the detection and confirmation of gross MSH2 and MLH1 genomic rearrangements. A total of nine nonfluorescent multiplex-PCRs were developed to analyze the 16 MSH2 and 19 MLH1 exons. Reliable multiplex amplifications and nonfluorescent peak quantitation were obtained with a limited number of cycles (≤ 25) using a denaturing HPLC (DHPLC) instrument under nondenaturing conditions. The results obtained by NFMP-HPLC were highly reproducible. The combined use of MLPA and NFMP-HPLC identified and independently confirmed putative MLH1 and MSH2 deletions in eight out of 50 unrelated patients with hereditary nonpolyposis colorectal cancer (HNPCC). In five cases, the deletions affected a single exon and in three cases multiple contiguous exons. These results were in agreement with breakpoint and complementary DNA (cDNA) analyses. Considering that MLPA and NFMP-HPLC are unlikely to be affected by the same artifacts, their combined use could also provide a robust and cost-effective strategy for routine screening and confirmation of putative rearrangements in other genes, especially when a single exon is involved or a precise characterization of breakpoints is not achieved.

AB - Large genomic rearrangements are recognized as playing a pathogenic role in an increasing number of human genetic diseases. It is important to develop efficient methods for the routine detection and confirmation of these germline defects. Multiplex ligation-dependent probe amplification (MLPA) is considered an early step for molecular diagnosis of several genetic disorders. However, artifacts might hamper the interpretation of MLPA analysis, especially when rearrangements involve a single exon. Therefore, rearrangements must be verified by two independent methods. In this study, we developed nonfluorescent multiplex-PCR coupled to high-performance liquid chromatography (NFMP-HPLC) and analyzed whether the use of this method combined with MLPA could be helpful in the detection and confirmation of gross MSH2 and MLH1 genomic rearrangements. A total of nine nonfluorescent multiplex-PCRs were developed to analyze the 16 MSH2 and 19 MLH1 exons. Reliable multiplex amplifications and nonfluorescent peak quantitation were obtained with a limited number of cycles (≤ 25) using a denaturing HPLC (DHPLC) instrument under nondenaturing conditions. The results obtained by NFMP-HPLC were highly reproducible. The combined use of MLPA and NFMP-HPLC identified and independently confirmed putative MLH1 and MSH2 deletions in eight out of 50 unrelated patients with hereditary nonpolyposis colorectal cancer (HNPCC). In five cases, the deletions affected a single exon and in three cases multiple contiguous exons. These results were in agreement with breakpoint and complementary DNA (cDNA) analyses. Considering that MLPA and NFMP-HPLC are unlikely to be affected by the same artifacts, their combined use could also provide a robust and cost-effective strategy for routine screening and confirmation of putative rearrangements in other genes, especially when a single exon is involved or a precise characterization of breakpoints is not achieved.

KW - Gene dosage

KW - HNPCC

KW - MLH1

KW - Molecular diagnosis

KW - MSH2

KW - Semiquantitative analysis

UR - http://www.scopus.com/inward/record.url?scp=33748993725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748993725&partnerID=8YFLogxK

U2 - 10.1002/humu.20386

DO - 10.1002/humu.20386

M3 - Article

C2 - 16941473

AN - SCOPUS:33748993725

VL - 27

SP - 1047

EP - 1056

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 10

ER -